Profile area - Life Science Technologies - LSX
The Life Science Technologies profile area includes interdisciplinary research in medicine, natural and engineering sciences, an area where basic research can be developed and contribute to new and important clinical applications.
Call for Seed Grant Proposals is now open
Interdisciplinary collaboration
Modern medicine and biomedical research are highly dependent on advanced life science technologies (LSX), designed to interface, augment, and provide a deeper understanding of complex biological systems. We live in an era of convergence when new and unexpected discoveries are generating radically new directions in biology, medicine, and technology for preventing, diagnosing, and treating diseases. At LiU, we are at the forefront of this development. With a firm foundation in engineering and science, we address problems that range from fundamental biomedical research to clinical medicine, with the ambition to create new knowledge and develop breakthrough technologies for the benefit of human health and well-being.
The overall aim of the LSX profile area is to further strengthen the interdisciplinary environment between the Faculty of Science and Engineering and the Faculty of Medicine and Health Sciences at LiU, ensuring that we will continue to pioneer and develop the technologies needed to address current and future global healthcare challenges.
Research Projects
The main research activities are focused on development of bio- and tissue interactive technologies for improved health and are centered around seven well-defined research areas that engage researchers from both the Faculty of Science and Engineering and the Faculty of Medicine and Health Sciences. By integrating expertise and resources from diverse fields, we aim to address challenging, multifaceted research questions and uncover solutions that would remain elusive through conventional approaches.
Research projects
Biointeractive molecular design
The targeting of enigmatic, complex disease systems with often highly disordered biological and structural properties severely suffers from slow progress due to the lack of appropriate research tools. By connecting expertise in molecular targeting with structural biology, biophysics, and novel sensing technologies we aim to invent, build, and tailor next-generation innovative methodologies to extend druggability and diagnostic options in cancer and neurodegenerative diseases.
Responsible PIs are Peter Nilsson and Maria Sunnerhagen.
Oligonucleotide nanocarrier systems
Responsible PIs are Maria Sunnerhagen and Edwin Jager.
Brain stimulation and monitoring of nerve signals
Responsible PIs are Karin Wårdell and Magnus Berggren.
Bioelectronics: In vivo-templated substrate-free bioelectronics and ligand/devices for optoelectronic sensing
Responsible PIs are Daniel Simon and Peter Nilsson.
Engineered skin tissue viability monitoring
Responsible PIs are Daniel Aili and Hanna Jonasson.
Bionic actuation of living biomaterials
Responsible PIs are Edwin Jager and Daniel Aili.
Fluorescing nanoprobes for brain tumor identification
Responsible PIs are Kajsa Uvdal and Karin Wårell.
